Globa Terra Acquisition Signs $324M M&A Deal with Nature’s Ledger Inc.
Globa Terra Acquisition Corp (SPAC) has entered into a definitive business combination agreement with Nature’s Ledger Inc., a carbon markets and environmental assets company. The transaction values Nature's Ledger at a pre-money equity value of approximately $323.8 million. Upon closing, the combined entity will operate under the Nature’s Ledger name as a publicly traded company.
Reliance Global Group Signs $3M M&A Deal with Skyportal Inc.
Reliance Global Group completed the acquisition of the Oblivus GPU cloud computing platform from Skyportal Inc. for $3 million in cash at closing. The deal includes up to $0.75 million in milestone-based cash payments and marks the company's entry into the AI infrastructure market, with plans to rebrand as GPU Exchange.
Value
$3M
Counterparty
Skyportal Inc.
“Oblivus gives us an established, revenue-generating platform to build on. We intend to grow this business dramatically.”
Ezra Beyman, Chairman and Chief Executive Officer
“Our focus now is execution. We are expanding GPU capacity, growing the customer base and working to convert the opportunities in front of us into revenue. GPU Exchange will bring these efforts together under one brand.”
DoubleVerify Holdings M&A Deal with Neptune BidCo US Inc.
DoubleVerify Holdings, Inc. provided a status update on its pending acquisition by Neptune BidCo US Inc., an affiliate of private equity firm Accel-KKR. The company announced it expects the merger to close during the fourth quarter of 2026, subject to remaining closing conditions. Upon completion, DoubleVerify will become a privately held, wholly owned subsidiary of Neptune BidCo.
Jbs Signs $553M M&A Deal with Flora Produtos de Higiene e Limpeza S.A.
JBS N.V. announced the acquisition of 100% of Flora, a Brazilian personal care and cleaning products company, for US$542 million, and Canal Rural, an agribusiness media company, for US$11 million. The transactions are being conducted with J&F Group, JBS's controlling shareholder, and will be paid primarily in JBS Class A common shares and BDRs. The acquisitions expand JBS's consumer products platform into the beauty, health, and wellness markets while leveraging its existing collagen and ingredient capabilities.
Value
$553M
Counterparty
Flora Produtos de Higiene e Limpeza S.A. and Canal Rural Produções Ltda.
Forge Nano Holdings Signs $55M M&A Deal with HzO, Inc.
Forge Nano Holdings, Inc. completed the acquisition of HzO, Inc. on November 4, 2026, through a merger of a wholly owned subsidiary into HzO. The transaction was valued at an aggregate purchase price of $55.0 million, paid through the issuance of 7,306,440 shares of Forge Nano common stock to HzO security holders.
Zymeworks M&A Deal with Theravance Biopharma, Inc.
Zymeworks Inc. filed an amendment to its previous 8-K to provide historical and pro forma financial statements following its completed acquisition of Theravance Biopharma, Inc. The merger involved a cash payment of $17.00 per share plus a contingent value right (CVR) tied to the future monetization and commercial success of ampreloxetine. The cash portion of the deal was financed through $350 million in non-recourse notes from OMERS Life Sciences and existing cash reserves.
Tidewater M&A Deal with Wilson, Sons Ultratug Participações S.A.
Tidewater Inc. filed an amendment to its previous 8-K to provide required audited financial statements and pro forma financial information following its completed acquisition of Wilson, Sons Ultratug Participações S.A. (now Tidewater Offshore do Brasil S.A.) and Atlantic Offshore Services S.A. The acquisition was originally completed on August 31, 2026.
Valor Energy Signs $3.6M M&A Deal with Glorious Star, LLC
Valor Energy Inc. entered into an amendment regarding its acquisition of the Youngstown Computing Center from Glorious Star, LLC for a total purchase price of $3.6 million. The amendment eliminates an escrow arrangement for the $360,000 down payment, allowing direct payment to the seller upon satisfactory due diligence, and clarifies that the acquisition of additional power capacity would be treated as a separate transaction. The closing is expected within thirty business days of the original October 18, 2026 effective date.
Surgery Partners Signs $6B M&A Deal with HealthSpan Partners
Surgery Partners announced an amendment to its merger agreement with HealthSpan Partners, increasing the cash consideration to $25.00 per share following an unsolicited competing proposal. The deal represents an enterprise value of approximately $6.0 billion and includes a 'Ticking Fee' if the merger does not close by March 1, 2027.
Value
$6B
Counterparty
HealthSpan Partners
“Our financial results in the third quarter reflect the impact of the successful Idaho Falls divestiture and sustained momentum in our core business, underscoring the value of our short-stay surgical platform. Additionally, the recently announced amended merger agreement with HealthSpan Partners serves as further validation of our unique offering, while representing a compelling outcome for our patients, physicians, stockholders, and other stakeholders.”
Park Dental Partners M&A Deal with Village Family Dental
Park Dental Partners completed its acquisition of the dental services organization supporting Village Family Dental, expanding its footprint into North Carolina. The transaction adds support for 12 practice locations and 47 doctors to the company's network. In connection with the deal, the company amended its credit agreement to increase its revolving credit commitment from $15 million to $25 million.
Kustom Entertainment, Inc. entered into an amendment to its definitive unit purchase agreement to acquire 100% of TFL, LLC (dba Tickets For Less). The amendment extends the outside termination date for the transaction from October 15, 2026, to December 18, 2026, to allow more time to satisfy customary closing conditions.
Kustom Entertainment, Inc. (Nasdaq: KUST) has signed an amendment to its definitive unit purchase agreement to acquire 100% of TFL, LLC, a wholesale ticketing distribution and live event technology platform. The amendment extends the closing timeline to no later than December 18, 2026, to allow for the completion of customary closing requirements.
Surgery Partners Signs $6B M&A Deal with HealthSpan Partners
Surgery Partners entered into an amendment to its merger agreement with HealthSpan Partners (an affiliate of Bon Secours Mercy Health), increasing the cash consideration to $25.00 per share. The deal includes a 'ticking fee' of up to $1.61 per share if closing is delayed past March 1, 2027, bringing the total enterprise value to approximately $6.0 billion. The amendment follows an unsolicited $28.00 per share competing proposal from a third party, which the board determined was less favorable due to regulatory and closing certainty provided by HealthSpan.
Value
$6B
Counterparty
HealthSpan Partners
“We are pleased to have reached this outcome, which reflects the rigorous focus of our Board of Directors and Special Committee throughout this process on delivering the best possible result for Surgery Partners and our stockholders. This transaction provides exceptional value for our stockholders, along with regulatory certainty and a closing expected in the near term.”
Eric Evans, Chief Executive Officer of Surgery Partners
Fox Corporation completed the acquisition of Roku, Inc. on November 6, 2026, for a combination of cash and FOX Class A Common Stock. This filing provides the required historical financial statements of Roku and pro forma financial information following the consummation of the transaction. Fox expects to realize synergies and operational efficiencies from the integration of Roku's streaming platform into its media business.
Inflection Point Acquisition Corp. VI M&A Deal with Quantum Space, LLC
Inflection Point Acquisition Corp. VI provided a status update on its pending merger with Quantum Space, LLC, announcing a Virtual Analyst Day to discuss the company's technology platform and mission pipeline. Upon completion of the business combination, the combined company is expected to list on the NYSE under the ticker symbol QSPC.
King Resources Global Signs $12.3M M&A Deal with Grand View Assets Limited
King Resources Global, Inc., through its subsidiary Heavenly Grace, entered into three purchase agreements to acquire a total of 19 collectible items for an aggregate consideration of approximately $12.34 million. The company will settle the acquisition costs by issuing common stock at a fixed price of $0.235 per share to the seller, Grand View Assets Limited.
InMed Pharmaceuticals Signs $490M M&A Deal with InMed Pharmaceuticals Inc.
Mentari Therapeutics completed its merger with InMed Pharmaceuticals Inc. and began trading on Nasdaq under the ticker 'MTRI'. In connection with the closing, the company completed $490 million in private placement financings to fund its pipeline of migraine prevention biologics, including MT-001 and MT-002.
Quanome Technologies entered into a definitive stock purchase agreement to acquire a 5% equity stake in QAI Labs Ltd., a life sciences technology company developing an AI-enabled antibody discovery platform. In exchange for 31,579 newly issued shares of QAI Labs, Quanome will issue 6,541,236 shares of its own common stock to the seller. The transaction advances Quanome's strategic pillar of applying quantum science and AI to molecular discovery.
Cvr Energy M&A Deal with Marathon Petroleum Corporation
CVR Energy is meeting with potential lenders regarding a proposed Term Loan B secured credit facility to fund a potential acquisition of assets from Marathon Petroleum Corporation. The target assets include the St. Paul Park, Minnesota and Mandan, North Dakota refineries along with associated marketing and logistics assets.
CDT Equity Inc. received a letter from former CEO Dr. Andrew Regan and Corvus Capital Limited indicating an intent to propose a non-binding acquisition of all outstanding common stock at $2.00 per share. The Board of Directors plans to form a Special Committee of independent directors to evaluate the potential proposal and other strategic alternatives.
CorMedix Signs $145M M&A Deal with Heron Therapeutics, Inc.
CorMedix Inc. has entered into a definitive agreement to acquire substantially all assets of Heron Therapeutics for $145 million in cash and 14,583,333 shares of common stock. The deal adds four commercial-stage products (ZYNRELEF, APONVIE, CINVANTI, and SUSTOL) to CorMedix's institutional care portfolio and includes up to $55 million in potential earn-out payments. To fund the transaction, CorMedix secured a new $75 million senior secured term loan facility from Pharmakon Advisors.
Abeona Therapeutics Signs $20M M&A Deal with Ellodi Pharmaceuticals, L.P.
Abeona Therapeutics acquired substantially all assets related to APT-1011 (now ABO-801), a Phase 3-ready candidate for eosinophilic esophagitis, from Ellodi Pharmaceuticals. The deal was structured with $20 million in upfront equity consideration (4,494,383 shares) and no upfront cash, with Ellodi eligible for $30 million upon FDA approval and up to $30 million in sales milestones plus royalties.
Value
$20M
Counterparty
Ellodi Pharmaceuticals, L.P.
“The acquisition of ABO-801 is an important step in building Abeona into a diversified commercial-stage company with multiple opportunities for value inflection, adding an asset with substantial revenue potential in a rapidly growing disease.”
Vish Seshadri, Ph.D., Chief Executive Officer of Abeona Therapeutics
Charles River Laboratories International Signs $470M M&A Deal with Frontage Holdings Corporation
Charles River Laboratories has entered into definitive agreements to acquire Frontage Holdings Corporation’s bioanalysis and DMPK operations in Exton, Pennsylvania for $470 million in cash. The deal includes up to $75 million in additional contingent payments and is intended to expand Charles River's clinical bioanalysis capabilities to support clients across the full drug development lifecycle. The transaction is expected to close in the first half of 2027.
TruGolf Holdings M&A Deal with Polymath Research Inc.
TruGolf Holdings, Inc. filed an amendment to its previous 8-K to provide required financial statements and pro forma information following its acquisition of Polymath Research Inc. The acquisition of the Canadian-based research firm was completed on October 8, 2026, pursuant to an agreement originally dated August 17, 2026.
Pono Capital Four Signs $200M M&A Deal with Blackstar Orbital Technologies Corporation
Pono Capital Four, Inc. entered into an amendment to its existing merger agreement with Blackstar Orbital Technologies Corporation, reducing the base purchase price from $380 million to $200 million. The amendment also increases the shares reserved for the post-closing equity incentive plan and extends the outside closing date from March 31, 2027, to June 30, 2027.
Rallybio Corporation has postponed the closing of its previously announced merger with Avenzo Therapeutics, Inc., which was originally expected to close on November 6, 2026. The delay is due to unsatisfied conditions related to the listing of the company's shares following the transaction. Consequently, the company has also delayed the funding and payment of its previously announced cash distribution to shareholders.
T3 Defense Signs $1.54M M&A Deal with KeepZone AI Inc.
T3 Defense Inc. completed the acquisition of KeepZone AI Inc. from Nexera Technologies Ltd. on November 4, 2026. The purchase price was increased to $1,539,800 and was settled through the issuance of 425,594 shares of T3 Defense common stock.
HeartSciences M&A Deal with Fortitude Mining Holdings, Inc.
HeartSciences Inc. provided a status update regarding its pending merger with Fortitude Mining HoldCo, LLC, a subsidiary of Digital Currency Group. The company issued supplemental proxy disclosures to address demand letters from purported shareholders alleging disclosure omissions, aiming to avoid potential litigation delays ahead of the November 19, 2026, shareholder vote.
NorthWestern Energy Group M&A Deal with Black Hills
NorthWestern Energy Group management is attending the EEI Financial Conference to provide a strategic update and reaffirm its 2026 non-GAAP earnings guidance. The accompanying presentation includes forward-looking details regarding a pending merger with Black Hills, including anticipated financial results, strategic rationale, and regulatory progress. The company reaffirmed its 2026 earnings guidance range of $3.68 to $3.83 per diluted share.
Lazard M&A Deal with Campbell Lutyens Holdings Limited
Lazard, Inc. filed a prospectus supplement to facilitate the potential resale of up to 9,416,817 shares of common stock by selling stockholders. These shares were previously issued as consideration for Lazard's acquisition of 100% of Campbell Lutyens Holdings Limited. The filing serves to register these shares for secondary sale, and Lazard will receive no proceeds from any such sales.